COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control

Pandemic dynamics and health care responses are markedly different during the COVID-19 pandemic than in earlier outbreaks. Compared with established infectious disease such as influenza, we currently know relatively little about the origin, reservoir, cross-species transmission and evolution of SARS...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Philippe Buchy, Yves Buisson, Otavio Cintra, Dominic E. Dwyer, Michael Nissen, Raul Ortiz de Lejarazu, Eskild Petersen
Format:	article
Langue:	EN
Publié:	Elsevier 2021
Sujets:	SARS-CoV-2 pandemic vaccine COVID-19 Infectious and parasitic diseases RC109-216
Accès en ligne:	https://doaj.org/article/e9e25a1cd5074a62a24bb65f96c8eab2
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

id	oai:doaj.org-article:e9e25a1cd5074a62a24bb65f96c8eab2
record_format	dspace
spelling	oai:doaj.org-article:e9e25a1cd5074a62a24bb65f96c8eab22021-11-30T04:14:21ZCOVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control1201-971210.1016/j.ijid.2021.09.045https://doaj.org/article/e9e25a1cd5074a62a24bb65f96c8eab22021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1201971221007529https://doaj.org/toc/1201-9712Pandemic dynamics and health care responses are markedly different during the COVID-19 pandemic than in earlier outbreaks. Compared with established infectious disease such as influenza, we currently know relatively little about the origin, reservoir, cross-species transmission and evolution of SARS-CoV-2. Health care services, drug availability, laboratory testing, research capacity and global governance are more advanced than during 20th century pandemics, although COVID-19 has highlighted significant gaps. The risk of zoonotic transmission and an associated new pandemic is rising substantially. COVID-19 vaccine development has been done at unprecedented speed, with the usual sequential steps done in parallel. The pandemic has illustrated the feasibility of this approach and the benefits of a globally coordinated response and infrastructure. Some of the COVID-19 vaccines recently developed or currently in development might offer flexibility or sufficiently broad protection to swiftly respond to antigenic drift or emergence of new coronaviruses. Yet many challenges remain, including the large-scale production of sufficient quantity of vaccines, delivery of vaccines to all countries and ensuring vaccination of relevant age groups. This wide vaccine technology approach will be best employed in tandem with active surveillance for emerging variants or new pathogens using antigen mapping, metagenomics and next generation sequencing.Philippe BuchyYves BuissonOtavio CintraDominic E. DwyerMichael NissenRaul Ortiz de LejarazuEskild PetersenElsevierarticleSARS-CoV-2pandemicvaccineCOVID-19Infectious and parasitic diseasesRC109-216ENInternational Journal of Infectious Diseases, Vol 112, Iss , Pp 300-317 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	SARS-CoV-2 pandemic vaccine COVID-19 Infectious and parasitic diseases RC109-216
spellingShingle	SARS-CoV-2 pandemic vaccine COVID-19 Infectious and parasitic diseases RC109-216 Philippe Buchy Yves Buisson Otavio Cintra Dominic E. Dwyer Michael Nissen Raul Ortiz de Lejarazu Eskild Petersen COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control
description	Pandemic dynamics and health care responses are markedly different during the COVID-19 pandemic than in earlier outbreaks. Compared with established infectious disease such as influenza, we currently know relatively little about the origin, reservoir, cross-species transmission and evolution of SARS-CoV-2. Health care services, drug availability, laboratory testing, research capacity and global governance are more advanced than during 20th century pandemics, although COVID-19 has highlighted significant gaps. The risk of zoonotic transmission and an associated new pandemic is rising substantially. COVID-19 vaccine development has been done at unprecedented speed, with the usual sequential steps done in parallel. The pandemic has illustrated the feasibility of this approach and the benefits of a globally coordinated response and infrastructure. Some of the COVID-19 vaccines recently developed or currently in development might offer flexibility or sufficiently broad protection to swiftly respond to antigenic drift or emergence of new coronaviruses. Yet many challenges remain, including the large-scale production of sufficient quantity of vaccines, delivery of vaccines to all countries and ensuring vaccination of relevant age groups. This wide vaccine technology approach will be best employed in tandem with active surveillance for emerging variants or new pathogens using antigen mapping, metagenomics and next generation sequencing.
format	article
author	Philippe Buchy Yves Buisson Otavio Cintra Dominic E. Dwyer Michael Nissen Raul Ortiz de Lejarazu Eskild Petersen
author_facet	Philippe Buchy Yves Buisson Otavio Cintra Dominic E. Dwyer Michael Nissen Raul Ortiz de Lejarazu Eskild Petersen
author_sort	Philippe Buchy
title	COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control
title_short	COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control
title_full	COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control
title_fullStr	COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control
title_full_unstemmed	COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control
title_sort	covid-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/e9e25a1cd5074a62a24bb65f96c8eab2
work_keys_str_mv	AT philippebuchy covid19pandemiclessonslearnedfrommorethanacenturyofpandemicsandcurrentvaccinedevelopmentforpandemiccontrol AT yvesbuisson covid19pandemiclessonslearnedfrommorethanacenturyofpandemicsandcurrentvaccinedevelopmentforpandemiccontrol AT otaviocintra covid19pandemiclessonslearnedfrommorethanacenturyofpandemicsandcurrentvaccinedevelopmentforpandemiccontrol AT dominicedwyer covid19pandemiclessonslearnedfrommorethanacenturyofpandemicsandcurrentvaccinedevelopmentforpandemiccontrol AT michaelnissen covid19pandemiclessonslearnedfrommorethanacenturyofpandemicsandcurrentvaccinedevelopmentforpandemiccontrol AT raulortizdelejarazu covid19pandemiclessonslearnedfrommorethanacenturyofpandemicsandcurrentvaccinedevelopmentforpandemiccontrol AT eskildpetersen covid19pandemiclessonslearnedfrommorethanacenturyofpandemicsandcurrentvaccinedevelopmentforpandemiccontrol
_version_	1718406837869477888

COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control

Documents similaires